Medication info
Aiklan Tablet 625 mg (Amoxicillin - Potassium Clavulanate)

Aiklan Tablet 625 mg (Amoxicillin - Potassium Clavulanate)

Prescription medicationTabletOral
Ingredient · strength
Amoxicillin Hydrate›500mg / 1 tabletDilute Potassium Clavulanate›212.73mg / 1 tablet
Manufacturer / importer
Boryung Biopharma Co., Ltd.
Appearance
This medicine is a white or almost white oval film-coated tablet.
Packaging
40 tablets (4 tablets/PTP*10)
Approval status
Active

MFDS item code 201804097 · Approved 2018.10.16 · Insurance code 670501120

Summary

Main use
Treatment of respiratory and ear, nose, and throat infections, genitourinary infections, and skin, bone, and dental infections
Who takes it
Adults · Children
Adult dose
The dose of this drug should be determined based on the patient's age, body weight, renal function, and severity of infection. Administer at the start of a meal to minimize potential gastrointestinal intolerance. Absorption of amoxicillin/clavulanate is optimized when administered at the start of a meal. Adults: Administer 250 mg/125 mg of amoxicillin/potassium clavulanate per dose orally 3 times daily, every 8 hours. For severe infections and respiratory tract infections, the dose may be increased to 500 mg/125 mg of amoxicillin/potassium clavulanate per dose. In patients with renal impairment, adjust the dose as appropriate according to creatinine clearance. Dosage adjustment is based on the maximum recommended dose of amoxicillin. No dosage adjustment is necessary in patients with creatinine clearance (creatinine clearance; CrCl) of 30 mL/min or greater. 10 ~ 30 mL/min : Administer 250mg/125mg of amoxicillin/potassium clavulanate per dose or 500mg/125mg of amoxicillin/potassium clavulanate per dose every 12 hours. 10 mL/min or less : Administer 250mg/125mg of amoxicillin/potassium clavulanate per dose or 500mg/125mg of amoxicillin/potassium clavulanate per dose every 24 hours. Hemodialysis : Administer 250mg/125mg of amoxicillin/potassium clavulanate per dose or 500mg/125mg of amoxicillin/potassium clavulanate per dose every 24 hours, administer an additional dose during dialysis, and repeat the dose at the end of dialysis. (Because serum concentrations of both amoxicillin and clavulanate decrease)
Child dose
Children aged 12 years or older or weighing 40 kg or more: Administer 250 mg/125 mg of amoxicillin/potassium clavulanate per dose orally 3 times daily, every 8 hours. For severe infections and respiratory tract infections, the dose may be increased to 500 mg/125 mg of amoxicillin/potassium clavulanate per dose. Children: Reduce the dose in the same manner.

Ingredients

Manufacturer
Boryung Biopharma Co., Ltd.

Efficacy & effects

Treatment of respiratory and ear, nose, and throat infections, genitourinary infections, and skin, bone, and dental infections

  • Acute and chronic bronchitis
  • lobar pneumonia
  • bronchopneumonia
  • empyema
  • lung abscess
  • tonsillitis
  • sinusitis
  • otitis media
  • cystitis
  • urethritis
  • pyelonephritis
  • pelvic infections
View approved original text

This medication is effective for the treatment of various bacterial infections. It is used for respiratory infections such as acute and chronic bronchitis, bronchopneumonia, empyema, and lung abscess, as well as tonsillitis, sinusitis, and otitis media. It also helps in the treatment of urogenital infections such as cystitis, urethritis, pyelonephritis and gonorrhea, and pelvic infections. It is effective for skin and soft tissue infections such as furuncles, abscesses, cellulitis, wound infections, and osteomyelitis. It is also used for the treatment of dental infections, targeting various pathogens including ampicillin and amoxicillin-resistant bacteria. Therefore, it is used for the improvement of several bacterial infections.

How to take

Adult dose

The dose of this drug should be determined based on the patient's age, body weight, renal function, and severity of infection. Administer at the start of a meal to minimize potential gastrointestinal intolerance. Absorption of amoxicillin/clavulanate is optimized when administered at the start of a meal. Adults: Administer 250 mg/125 mg of amoxicillin/potassium clavulanate per dose orally 3 times daily, every 8 hours. For severe infections and respiratory tract infections, the dose may be increased to 500 mg/125 mg of amoxicillin/potassium clavulanate per dose. In patients with renal impairment, adjust the dose as appropriate according to creatinine clearance. Dosage adjustment is based on the maximum recommended dose of amoxicillin. No dosage adjustment is necessary in patients with creatinine clearance (creatinine clearance; CrCl) of 30 mL/min or greater. 10 ~ 30 mL/min : Administer 250mg/125mg of amoxicillin/potassium clavulanate per dose or 500mg/125mg of amoxicillin/potassium clavulanate per dose every 12 hours. 10 mL/min or less : Administer 250mg/125mg of amoxicillin/potassium clavulanate per dose or 500mg/125mg of amoxicillin/potassium clavulanate per dose every 24 hours. Hemodialysis : Administer 250mg/125mg of amoxicillin/potassium clavulanate per dose or 500mg/125mg of amoxicillin/potassium clavulanate per dose every 24 hours, administer an additional dose during dialysis, and repeat the dose at the end of dialysis. (Because serum concentrations of both amoxicillin and clavulanate decrease)

Child dose

Children aged 12 years or older or weighing 40 kg or more: Administer 250 mg/125 mg of amoxicillin/potassium clavulanate per dose orally 3 times daily, every 8 hours. For severe infections and respiratory tract infections, the dose may be increased to 500 mg/125 mg of amoxicillin/potassium clavulanate per dose. Children: Reduce the dose in the same manner.

Precautions

This medication should not be used in patients with hypersensitivity to specific components or to beta-lactam antibiotics. Particularly, caution is needed in patients with viral infections such as infectious mononucleosis or lymphocytic leukemia due to a high risk of rash. Patients with liver function issues should avoid use, as it may recur liver dysfunction symptoms. Patients with impaired liver or kidney function should use this medication with caution, requiring adjustments in dosing intervals or amounts. Patients with allergies, the elderly, or those in poor general health should be administered this medication carefully, as there may be signs of vitamin K deficiency. If gastrointestinal symptoms such as vomiting or diarrhea occur, it may interfere with drug absorption. This medication may cause gastrointestinal adverse reactions like diarrhea, vomiting, abdominal pain, or loss of appetite; if symptoms worsen, consult a physician immediately. Regular liver function tests should be conducted, as abnormalities or jaundice may appear, particularly in those over 60 years of age. Serious skin adverse reactions, such as rash or itching, including severe cases like Stevens-Johnson syndrome, may occur; if unusual symptoms appear, administration should be stopped immediately. Regular blood tests are necessary as abnormality may arise, such as leukopenia or thrombocytopenia. Nervous system symptoms such as anxiety, confusion, or convulsions may rarely occur, so if these symptoms arise, medical staff should be notified immediately. Patients with kidney function issues may present acute renal failure or hematuria, requiring careful monitoring. Use of this medication may disrupt the balance of normal intestinal flora, potentially leading to fungal infections such as candidiasis. Patients should report any bleeding symptoms immediately, as vitamin K deficiency may lead to bleeding tendencies. This medication may interact with other drugs; therefore, inform your doctor or pharmacist of any other medications you are taking. Women who are pregnant or may become pregnant are advised to avoid using this medication, especially during the first three months. Similar caution should be taken if breastfeeding, as adverse reactions may occur in infants. Children, particularly those under the age of 12 or weighing less than 40 kg, have limited experience with this medication, so its use is not recommended. The elderly may experience a higher incidence of adverse reactions due to decreased physiological function, thereby doses and intervals should be adjusted and used cautiously. During treatment with this medication, certain clinical tests, such as urine tests or liver function tests, may yield altering results; thus, you should inform testing staff that you are taking this medication. In cases of overdose, gastrointestinal symptoms, renal dysfunction, or neurological symptoms may arise; if symptoms appear, seek medical attention immediately. Medications should be stored in a dry container to prevent moisture and kept at a cool temperature between 1°C and 25°C. Proper storage will help maintain the medication's efficacy and prevent deterioration.

Side effects

  • Diarrhea
  • pseudomembranous colitis
  • dyspepsia
  • stomatitis
  • gastritis
  • glossitis
  • black hairy tongue
  • nausea
  • vomiting
  • anorexia
Show 75 more
  • abdominal pain
  • abdominal bloating
  • constipation
  • colonic pain
  • hyperacidity
  • loose stools
  • xerostomia
  • acute pancreatitis
  • candidiasis
  • antibiotic-associated colitis
  • blood in stool
  • itching
  • erythema multiforme
  • Stevens-Johnson syndrome
  • toxic epidermal necrolysis
  • vesiculobullous dermatitis
  • acute generalized pustular dermatosis
  • eosinophilia
  • angioedema
  • anaphylaxis
  • serum sickness syndrome
  • hypersensitivity vasculitis
  • bronchospasm
  • dyspnea
  • laryngeal edema
  • anaphylactic shock
  • leukopenia
  • thrombocytopenia
  • hemolytic anemia
  • anemia
  • thrombocytopenic purpura
  • eosinophilia
  • leukemia
  • agranulocytosis
  • lymphopenia
  • thrombocytosis
  • bone marrow suppression
  • prolonged bleeding time
  • prolonged prothrombin time
  • vaginal itching
  • vaginal pain
  • increased secretion
  • anxiety
  • restlessness
  • behavioral changes
  • confusion
  • drowsiness
  • insomnia
  • hyperactivity
  • dizziness
  • headache
  • convulsions
  • antispasmodic
  • fever
  • altered consciousness
  • aseptic meningitis
  • acute renal failure
  • interstitial nephritis
  • hematuria
  • crystalluria
  • symptoms of vitamin K deficiency
  • symptoms of vitamin B complex deficiency
  • linear IgA disease
  • dysgeusia
  • malaise
  • dermatitis
  • oral edema
  • gastric pain
  • fluid and electrolyte imbalance
  • rash
  • hyperactivity
  • drowsiness
  • symptoms of renal failure
  • epileptic seizures
  • hypersensitivity shock

Not everyone experiences these, and they can vary from person to person.

Storage

This medicine should be contained in a sealed container to prevent moisture and should be stored at a cool temperature maintained between 1°C to 25°C. Proper storage will help maintain the efficacy of the medication and prevent degradation.

Appearance and packaging

Appearance

This medicine is a white or almost white oval film-coated tablet.

Package unit

40 tablets (4 tablets/PTP*10)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.